Tyramine exerts hypolipidemic and anti-obesity effects in vivo
DOI:
https://doi.org/10.1590/s2175-97902022e201191Palavras-chave:
Polyphenol, Oral toxicity, Hyperlipidemia, Cholesterol oxidation, ObesityResumo
Obesity and dyslipidemia are conditions often associated with cardiovascular risk, inflammation, oxidative stress, and death. Thus, a new approach has been highlighted to promote research and development of pharmacological tools derived from natural sources. Among the most widely studied groups of substances, polyphenols such as tyramine stand out. This study investigated hypolipidemic and anti-obesity properties of tyramine. Oral toxicity evaluation, models of dyslipidemia and obesity were used. To induce dyslipidemia, Poloxamer-407 (P-407) was administered intraperitoneally. In the hypercholesterolemic and obesity model, specific diet and oral tyramine were provided. After 24h of P-407 administration, tyramine 2 mg/kg (T2) decreased triglycerides (TG) (2057.0 ± 158.5 mg/dL vs. 2838 ± 168.3 mg/dL). After 48h, TG were decreased by T2 (453.0 ± 35.47 vs. 760.2 ± 41.86 mg/dL) and 4 mg/kg (T4) (605.8 ± 26.61 760.2 ± 41.86 mg/dL). T2 reduced total cholesterol (TC) after 24h (309.0 ± 11.17 mg/dL vs. 399.7 ± 15.7 mg/dL); After 48h, 1 mg/kg (T1) (220.5 ± 12.78 mg/dL), T2 (205.8 ± 7.1 mg/dL) and T4 (216.8 ± 12.79 mg/dL), compared to P-407 (275.5 ± 12.1 mg/dL). The treatment decreased thiobarbituric acid reactive substances and nitrite in liver, increased superoxide dismutase, reduced the diet-induced dyslipidemia, decreasing TC around 15%. Tyramine reduced body mass, glucose, and TC after hypercaloric feed. Treatment with 5 mg/L (0.46 ± 0.04 ng/dL) and 10 mg/L (0.44 ± 0.02 ng/dL) reduced plasma insulin (1.18 ± 0.23 ng/dL). Tyramine increased adiponectin at 5 mg/L (1.02 ± 0.02 vs. 0.83 ± 0.02 ng/mL) and 10mg/L (0.96 ± 0.04 ng/mL). In conclusion, tyramine has low toxicity in rodents, has antioxidant effect, reduces plasma triglycerides and cholesterol levels. However, further studies should be conducted in rodents and non-rodents to better understand the pharmacodynamic and pharmacokinetic properties of tyramine.
Downloads
Referências
Ahn CH, Choi SH. New drugs for treating dyslipidemia: Beyond statins. Diabetes Metab J. 2015;39(2):87-94.
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):176-185.
Amaro CAB, González-Cortazar M, Herrera-Ruiz M, Román-Ramos R, Aguilar-Santamaría L, Tortoriello J, et al. Hypoglycemic and hypotensive activity of a root extract of Smilax aristolochiifolia, standardized on N-trans-feruloyl-tyramine. Molecules. 2014;19(8):11366-84.
Bedê TP, de Jesus V, Rosse de Souza V, Mattoso V, Abreu JP, Dias JF, et al. Effect of grape juice, red wine and resveratrol solution on antioxidant, anti-inflammatory, hepactic function and lipid profile in rats feds with high-fat diet. Nat Prod Res. 2020;1-6.
Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, et al. Inflammatory and cholesterol risk in the FOURIER trial. Circulation. 2018;138(2):131-40.
Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol. 2003;43:175-97.
Carpéné C, Galitizki J, Belles C, Zakaroff-Girard A. Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food. J Physiol Biochem. 2018;74(4):623-633. https://pubmed.ncbi. nlm.nih.gov/30039351/ >>
» https://pubmed.ncbi. nlm.nih.gov/30039351/ >>
Chang JJ, Chung DJ, Lee YJ, Wen BH, Jao HY, Wang CJ. Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice. J Agric Food Chem. 2017;65(42):9255-65.
Charron MJ, Williams L, Seki Y, Du XQ, Chaurasia B, Saghatelian A, et al. Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice. Diabetes. 2020;69(8):1650-1661.
Cho SH, Park EJ, Kim EO, Choi SW. Study on the hypochlolesterolemic and antioxidative effects of tyramine derivatives from the root bark of Lycium chenese Miller. Nutr Res Pract. 2011;5(5):412-20.
Ehile EH, Goze NB, Kouakou KL, Yapo AP, Ehile EE. Acute toxicity and gastric anti-ulcer activity of an aqueous extract of the leaves of Macaranga barteri Mll. Arg (Euphorbiaceae) on rat models. J Med Plants Res. 2018;12(9):96-105.
Estadella D, Oyama LM, Dâmaso AR, Ribeiro EB, Oller Do Nascimento CM. Effect of Palatable Hyperlipidic Diet on Lipid Metabolism of Sedentary and Exercised Rats. Nutrition. 2004;20(2):218-24.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. 1. Evidence From Genetic, Epidemiologic, and Clinical Studies. A Consensus Statement From the European Atherosclerosis Society Consensus Panel. Eur Hear J. 2017;38(32):2459-72.
Franco R, Navarro G, Martínez-Pinilla E. Hormetic and mitochondria-related mechanisms of antioxidant action of phytochemicals. Antioxidants. 2019;8(9):373.
Gainetdinov RR, Hoener MC, Berry MD. Trace amines and their receptors. Pharmacol Rev. 2018;70(3):549-620.
Gao X, Wang C, Chen Z, Chen Y, Santhanam RK, Xue Z, et al. Effects of N-trans-feruloyltyramine isolated from laba garlic on antioxidant, cytotoxic activities and H2O2-induced oxidative damage in HepG2 and L02 cells. Food Chem Toxicol. 2019;130:130-41.
Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620-36.
Green LC, Tannenbaum SR, Goldman P. Nitrate synthesis in the germfree and conventional rat. Science. 1981;212(4490):56-8.
Hafez Hetta M, Moawad AS, Abdel-Aziz Hamed M, Sabri AI. In-vitro and in-vivo hypolipidemic activity of spinach roots and flowers. Iran J Pharm Res. 2017;16(4):1509-19.
Hedayatnia M, Asadi Z, Zare-Feyzabadi R, Yaghooti-Khorasani M, Ghazizadeh H, Ghaffarian-Zirak R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19(1):42.
Iepsen UW, Munch GW, Ryrsø CK, Secher NH, Lange P, Thaning P, et al. Muscle α-adrenergic responsiveness during exercise and ATP-induced vasodilation in chronic obstructive pulmonary disease patients. Am J Physiol Heart Circ Physiol. 2018;314(2):H180-7.
Ince S, Arslan-Acaroz D, Demirel HH, Varol N, Ozyurek HA, Zemheri F, et al. Taurine alleviates malathion induced lipid peroxidation, oxidative stress, and proinflammatory cytokine gene expressions in rats. Biomed Pharmacother. 2017;96:263-8.
Jackson EK, Zhang Y, Cheng D. Alkaline phosphatase inhibitors attenuate renovascular responses to norepinephrine. Hypertension. 2017;69(3):484-93.
Johnston TP. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: A review of findings to date. J Cardiovasc Pharmacol. 2004;43(4):595-606.
Johnston TP, Korolenko TA, Sahebkar A. P-407-induced mouse model of dose-controlled hyperlipidemia and atherosclerosis: 25 Years later. J Cardiovasc Pharmacol . 2017;70(5):339-52.
Kaabia Z, Poirier J, Moughaizel M, Aguesse A, Billon-Crossouard S, Fall F, et al. Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species. Nature. 2018;8(1):15893.
Kim HY, Jeong DM, Jung HJ, Jung YJ, Yokozawa T, Choi JS. Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Biol Pharm Bull. 2008;31(1):76-8.
Liao J, Liu B, Zhong W, Wang GD, Xu YL, Chen X. Protective effect of Lycium barbarum polysaccharides against high-fat diet-induced renal injury and lipid deposition in rat kidneys. J Biol Regul Homeost Agents. 2019;33(1):7-17.
Lino CS, Sales TP, Gomes PB, do Amaral JF, Alexandre FSO, Silveira ER, et al. Anti-diabetic activity of a fraction from Cissus verticillata and tyramine, its main bioactive constituent, in alloxan-induced diabetic rats. Am J Pharmacol Toxicol. 2007;2(4):178-88.
Lippi G, Montagnana M, Salvagno GL, Guidi GC. Influence of stable, long-term treatment with phenobarbital on the activity of serum alanine aminotransferase and γ-glutamyltransferase. Br J Biomed Sci. 2008;65(3):132-5.
Malekmohammad K, Sewell RDE, Rafieian-Kopaei M. Antioxidants and atherosclerosis: Mechanistic aspects. Biomolecules. 2019;9(8):301.
Masuda D, Yamashita S. Postprandial hyperlipidemia and remnant lipoproteins. J Atheroscler Thromb. 2017;24(2):95-109.
Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP. Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2. J Hypertens. 2017;35(10):2059-68.
Meck JV, Martin DS, D’Aunno DS, Waters WW. Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function. J Cardiovasc Pharmacol . 2003;41(1):126-31.
Mihara M, Uchiyama M, Fukuzawa K. Thiobarbituric acid value on fresh homogenate of rat as a parameter of lipid peroxidation in aging, CCl4 intoxication, and vitamin E deficiency. Biochem Med. 1980;23(3):302-11.
Morin N, Visentin V, Calise D, Marti L, Zorzano A, Testar X, et al. Tyramine stimulates glucose uptake insulinsensitive tissues in vitro and in vivo via its oxidation by amine oxidases. J Pharmacol Exp Ther. 2002;303(3):1238-47.
Oecd. OECD/OCDE 407 OECD Guidelines for the Testing of Chemicals. Repeated Dose 28-Day Oral. Toxicity Study in Rodents. Introduction. 2008.
Oecd. OECD/OCDE 423 OECD Guideline for Testing of Chemicals. Acute Oral Toxicity-Acute Toxic Class Method. Introduction. 2001.
Pessione E, Cirrincione S. Bioactive molecules released in food by lactic acid bacteria: Encrypted peptides and biogenic amines. Front Microbiol. 2016;7:876.
Ponnuswamy P, Schröttle A, Ostermeier E, Grüner S, Huang PL, Ertl G, et al. eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE−/− Mice. PLoS One. 2012;7(1):e30193.
Razavian M, Nie L, Challa A, Zhang J, Golestani R, Jung JJ, et al. Lipid lowering and imaging protease activation in atherosclerosis. J Nucl Cardiol. 2014;21(2):319-28.
Rosenson RS. Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities. Atherosclerosis. 2004;173(1):1-12.
Sánchez Macarro M, Martínez Rodríguez JP, Bernal Morell E, Pérez-Piñero S, Victoria-Montesinos D, García-Muñoz AM, et al. Effect of a Combination of Citrus Flavones and Flavanones and Olive Polyphenols for the Reduction of Cardiovascular Disease Risk: An Exploratory Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects. Nutrients. 2020;12(5):1475.
Shabana, Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis . 2020;19(1):73.
Siemionow K, Teul J, Drągowski P, Pałka J, Miltyk W. New potential biomarkers of acetaminophen-induced hepatotoxicity. Adv Med Sci. 2016;61(2):325-30.
de Sousa ELH, Cavalcante JEA, de Sousa DF, Ferreira JM, Meneses RRC, Sousa DL, et al. Comparison of early cardiovascular risk among Brazilian and African university students. Clin Biochem. 2020;75:7-14.
Subra C, Fontana E, Visentin V, Testar X, Carpéné C. Tyramine and benzylamine partially but selectively mimic insulin action on adipose differentation in 3T3-L1 cells. J Physiol Biochem . 2003;59(3):209-16.
Subramaniam S, Ramachandran S, Uthrapathi S, Rajamanickam V, Dubey G. Anti-hyperlipidemic and Antioxidant Potential of Different Fractions of Terminalia Arjuna Roxb. Bark Against PX-407 Induced Hyperlipidemia. Indian J Exp Biol. 2011;49(4):282-8.
Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497-500.
Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, et al. Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: Safety, efficacy, and place in therapy. Vasc Health Risk Manag. 2017;13:29-41.
Til HP, Falke HE, Prinsen MK, Willems MI. Acute and subacute toxicity of tyramine, spermidine, spermine, putrescine and cadaverine in rats. Food Chem Toxicol . 1997;35(3-4):337-48.
Valentovic M. Simvastatin. In: xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc. 2007. p.1-4.
Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA. Drug-induced bile duct injury. Biochim Biophys Acta Mol Basis Dis. 2018;1864 (4 Pt B):1498-506.
Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D. Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem. 2007;18(2):105-12.
Yalamanchili C, Chittiboyina AG, Haider S, Vasquez Y, Khan S, do Carmo JM, et al. In search for potential antidiabetic compounds from natural sources: docking, synthesis and biological screening of small molecules from Lycium spp. (Goji). Heliyon. 2020;6(1):e02782.
Ye X, Zhang C. Effects of hyperlipidemia and cardiovascular diseases on proliferation, differentiation and homing of mesenchymal stem cells. Curr Stem Cell Res Ther. 2017;12(5):377-387.
Zhang Y, Feng F, Chen T, Li Z, Shen QW. Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice. J Ethnopharmacol. 2016;192:256-63.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
